The impact of COVID-19 pandemic on diagnosis and management of gastrointestinal cancers

• Main Authors: Byung Soo Yoo (Author), Ankit Patel (Author), Kevin V. Houston (Author), Alejandra Vargas (Author), Ana Rosa Vilela Sangay (Author), Steve M. D'Souza (Author), David A. Johnson (Author)
• Format: Book
• Published: Open Exploration Publishing Inc., 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.37349/emed.2023.00147; 2692-3106
• Keywords: covid-19 pandemic; gastrointestinal cancer; gastric cancer; cancer screening; mortality; prognosis; Other systems of medicine; RZ201-999
• Source: Exploration of Medicine, Vol 4, Iss 3, Pp 356-362 (2023)

Gastrointestinal (GI) cancer is one of the leading causes of death that affect many patients around the world. The coronavirus disease 2019 (COVID-19) pandemic significantly impacted our healthcare system in large that diagnosis and management of GI cancer have suffered with a reduction in cancer screening. This review will describe the current practices of cancer screening during COVID-19 pandemic and summarize how each GI cancer (esophageal, gastric, colorectal, and hepatocellular cancers) has been affected by COVID-19. World widely there has been a decreasing trend in screening, diagnosis, and management of GI cancers during the COVID-19 pandemic. Many healthcare institutions are now observing the effect of this change and implementing practice variations to adapt to the pandemic.